Regenxbio Cash from Operations (TTM) Analysis

Regenxbio Inc (RGNX)

15.69 -0.42 (-2.61%) USD | NASDAQ | Apr 19, 16:00

15.69 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-218.41M
September 30, 2023	-217.02M
June 30, 2023	-218.07M
March 31, 2023	-232.50M
December 31, 2022	-207.49M
September 30, 2022	173.38M
June 30, 2022	181.33M
March 31, 2022	207.01M
December 31, 2021	218.88M
September 30, 2021	-83.15M
June 30, 2021	-77.11M
March 31, 2021	-62.54M
December 31, 2020	-54.06M
September 30, 2020	-119.04M
June 30, 2020	-111.73M
March 31, 2020	-113.98M
December 31, 2019	-107.70M

Date	Value
September 30, 2019	-86.34M
June 30, 2019	-76.74M
March 31, 2019	17.22M
December 31, 2018	104.65M
September 30, 2018	94.96M
June 30, 2018	97.38M
March 31, 2018	17.62M
December 31, 2017	-57.99M
September 30, 2017	-64.59M
June 30, 2017	-59.27M
March 31, 2017	-58.15M
December 31, 2016	-48.56M
September 30, 2016	-32.58M
June 30, 2016	-29.16M
March 31, 2016	-28.73M
December 31, 2015	-22.52M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-232.50M

Minimum

Mar 2023

218.88M

Maximum

Dec 2021

-63.44M

Average

-86.34M

Median

Sep 2019

Cash from Operations (TTM) Benchmarks